Neutralizing Antibodies Against H5N1 Influenza
Author Information
Author(s): Lim Angeline PC, Chan Conrad EZ, Wong Steven KK, Chan Annie HY, Ooi Eng Eong, Hanson Brendon J
Primary Institution: Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore
Hypothesis
The development of therapeutic antibodies against epitopes that lie outside of the antigenic sites may provide some resistance against virus escape.
Conclusion
Five antibodies were identified that can neutralize H5N1 virus-like particles, suggesting potential for use in passive immunization.
Supporting Evidence
- Five antibodies exhibited neutralization of H5N1-VLP uptake in a dose-dependent manner.
- Antibodies were selected from a naïve human Fab library using sequential panning against antigenically distinct H5N1 strains.
- The identified antibodies showed binding to conserved regions of hemagglutinin, which may help in future pandemics.
Takeaway
Scientists found five special antibodies that can stop a dangerous flu virus from getting into cells, which could help protect people during a flu outbreak.
Methodology
The study used a combination of panning strategies against hemagglutinin from various H5N1 isolates to select antibodies from a human Fab library.
Limitations
Further studies are needed to determine the in vivo protective capacity of the antibodies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website